RE: Singer Capital Markets1 Jul 2025 08:08
I've spent days researching this share.
Prospectus - main risk identified as protecting the patents - USA Patent now protected for whole of the Central Nervous System Library. IP purchased from Equasy Ltd, 100% owned outright.
Funding - Raised, outsourced lab work, controlling costs.
How to get the message out there - Dennis Purcell, Renata Crome, David Nutt, Pharma Ventures, Singers Capital Markets.
Are there still risks - of course, everything has risk, but it has a very good risk profile imo.
The broker note should help set a solid base under the S.P. then other industry figure write ups and newsflow should edge this upwards throughout 2025.